Skip to main
AVNT
AVNT logo

Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp (AVNT) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Avient Corp has demonstrated strong performance, with organic sales increasing by 5% and healthcare sales witnessing double-digit growth, specifically a 14% year-over-year rise in the first half of 2025. The company benefits from a diversified product portfolio across multiple industries, and four out of nine key end markets contributing to 40% of its sales are experiencing growth this year. Despite anticipated challenges in the consumer end market for the second half of 2025, the overall outlook remains positive, bolstered by resilient sales in healthcare and other segments.

Bears say

Avient Corp has experienced fluctuating organic sales, with a decline of approximately 2% in 1Q24, followed by modest growth of 5% in 2Q and 4Q, and a significant 9% increase in 3Q, signaling potential instability in revenue performance. The demand for chemicals has been weakening since mid-2025, raising concerns over potential volume declines in the second half of 2025, which could negatively impact future financial results. Despite a recent decrease in the dollar's value, which may offer some benefits, the underlying trends in demand suggest increasing risks for Avient's growth and financial health.

Avient Corp (AVNT) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avient Corp (AVNT) Forecast

Analysts have given Avient Corp (AVNT) a Buy based on their latest research and market trends.

According to 6 analysts, Avient Corp (AVNT) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $45.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $45.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avient Corp (AVNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.